In this issue:

Economic, Tech changes drive lab concerns, The Dark Report provides insights from the Executive War College speakers about how clinical labs can use business strategies and tactics to handle the new tariffs, future regulations, and artificial intelligence (AI). Also, this issue provides guidance on how labs and pathologists should prepare for payer audits.

View Issue TOC

In this issue:

Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.

View Issue TOC

In this issue:

In the fourth and final article in the series, The Dark Report discusses ways to use price transparency during pathology contract talks. Also, global IVD companies issue their fourth quarter earnings reports showing a mixed bag of results.

View Issue TOC

In this issue:

A bold new technology has entered the European lab marketplace, with the introduction of an autonomous robotic phlebotomy device, already in service at a Netherlands hospital. Also, The Dark Report announces its sale to LabX Media Group of Ontario Canada.

View Issue TOC

In this issue:

Ongoing advances in information technology and cloud storage have increased data sharing and analysis capabilities throughout the healthcare industry. In this issue, The Dark Report dives deep into how today’s pathologists and practice administrators can leverage new digital pathology workflows and artificial intelligence image analysis solutions to efficiently store/retrieve “new data” generated by radiologists, cardiologists, and anatomic pathology groups. The Dark Report provides the pathology profession’s first look at this still-nascent market segment on pages 3-6

View Issue TOC

In this issue:

View Issue TOC

In this issue:

The Dark Report examines how AI is being used to predict the outcomes of FDA LDT lawsuits. Also, this issue is Part Two of a series about boosting pathology compensation in different settings, including hospitals. Two experienced pathology consultants identify the most effective approaches when negotiating Part A pathology agreements with hospitals and health systems, along with how to use data to bolster these negotiations.

View Issue TOC

In this issue:

This issue examines the top 10 stories from 2024 with the FDA’s LDT rule dominating lab industry headlines, while financial woes dog the entire healthcare sector. Another Top 10 Lab Industry Story centers around the federal government’s final rule on healthcare data interoperability and will help labs that must interface with other providers.

View Issue TOC

In this issue:

Two different federal lawsuits that challenge the authority of the federal Food and Drug Administration (FDA) to regulate laboratory developed tests (LDTs) will be combined. Plaintiffs and the government in both cases agreed to move forward on this basis.

View Issue TOC

In this issue:

Quest and Labcorp have been targeted by class action lawsuits involving internet tracking technology. Other lab companies could be next. Also, The Dark Report examines a comprehensive report on denials and appeals of laboratory claims by payers. Finally, Labcorp and Quest show healthy Q3 earnings.

View Issue TOC